Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries / Edition 1

Hardcover (Print)
Buy New
Buy New from BN.com
Buy Used
Buy Used from BN.com
(Save 41%)
Item is in good condition but packaging may have signs of shelf wear/aging or torn packaging.
Condition: Used – Good details
Used and New from Other Sellers
Used and New from Other Sellers
from $92.99
Usually ships in 1-2 business days
(Save 25%)
Other sellers (Hardcover)
  • All (9) from $92.99   
  • New (5) from $98.18   
  • Used (4) from $92.99   


To improve the ways they currently manage projects and programs, pharmaceutical and biotechnology companies need reliable stewardship to direct future strategies. Unlike other industry sectors, they have yet to fully embrace the effective integrated processes of Portfolio, Program, and Project Management, otherwise referred, to as P3M, to position themselves favorably in meeting challenges unique to the drug development business.

Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology, Industries illustrates how high-quality program and project management is crucial for drug companies to remain competitive, to deliver good returns to investors, and ultimately to bring novel personalized medicine to patients with:

A combination of theoretical insights and pragmatic examples from professionals who are all working in the industry

Case studies with very detailed, real-life examples of how the management of drug development is actually done

Answers the pharmaceutical industry needs to streamline and make the drug development process more efficient

The full spectrum of management processes needed from the operationalization of corporate strategy by portfolio management processes through to practical project control processes

Carefully divided into three main sections to cover topics such as the impact of organizational size on P3M; planning and control; and reducing product safety risk, this informative reference is structured to align both novices and professionals in drug program management with success in the wake of emerging trends.

Read More Show Less

Product Details

  • ISBN-13: 9780470049662
  • Publisher: Wiley
  • Publication date: 4/5/2010
  • Edition description: New Edition
  • Edition number: 1
  • Pages: 352
  • Sales rank: 1,059,287
  • Product dimensions: 6.30 (w) x 9.30 (h) x 1.00 (d)

Meet the Author

Pete Harpum is a Director of Harpum Consulting and has been consulting on Portfolio, Program, and Project Management (P3M) for some ten years. He chairs and contributes to many conferences and symposiums on P3M. Mr. Harpum's other activities include postgraduate lecturing and research on P3M for three world-class universities, and supporting the Association for Project Management, Project Management Institute, and the Drug Information Association in various ways.

Read More Show Less

Table of Contents

Preface ix

Acknowledgments xi

About the Authors xiii

Part 1 The Life Science Industry Context for Portfolio, Program, and Project Management

1 A Review of Project Management in Life Science Industry Sectors Thomas R. Dunson 3

2 The Impact of Organizational Size on Drug Project Management Eric Morfin 21

3 Drug Development in Biotechnology and How We Can Do It Better Susan Linna 33

Part 2 The Portfolio, Program, and Project Management Approaches and Processes

4 An Overview of the Organization and Processes of Portfolio, Program, and Project Management Pete Harpum 53

5 Portfolio Management in the Pharmaceutical Industry: Balancing Corporate Need with the Reality of Delivering Products to the Market John Bennett 59

6 Program Management in Drug Development Pauline Stewart-Long 85

7 Project Control Martin Powell 101

8 Managing Uncertainty in Drug Projects Pete Harpum Thomas R. Dunson 135

9 Managing Drug Safety Risk Thomas R. Dunson Eric Morfin 155

10 Developing Program Strategy Pete Harpum 175

11 Developing Products with "Added Value" Trevor J. Brown Stephen Allport 197

Part 3 Integrating the Processes

12 Integrated Business Processes to Support Cross-Functional Drug Development Martin D. Hynes III 227

13 Integrated Drug Development From Gradle to Grave and from Lab to Market Stephen Allport Terry Cooke-Davies 239

14 The Development of P3M Capability in Drug Development Organizations John Arrowsmith Patrick Grogan Bob Moore 259

15 Implementing Portfolio, Program, and Project Management Best Practices in Drug Development Organizations Pete Harpum Ashley Jamieson Inge Fisher 287

Bibliography 311

Index 313

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star


4 Star


3 Star


2 Star


1 Star


Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation


  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)